preludetx.comHealthcareFounded: 2016Funding to Date: $95MM
Prelude Therapeutics is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
For more details on financing and valuation for Prelude Therapeutics, register or login.
View Enterprise Value for Prelude Therapeutics.
To read this article and more news on Prelude Therapeutics, register or login.